A detailed history of Hexagon Capital Partners LLC transactions in Viatris Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 4,534 shares of VTRS stock, worth $56,765. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,534
Previous 5,174 12.37%
Holding current value
$56,765
Previous $54,000 3.7%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$10.32 - $12.13 $6,604 - $7,763
-640 Reduced 12.37%
4,534 $52,000
Q2 2024

Jul 12, 2024

SELL
$10.05 - $12.02 $8,160 - $9,760
-812 Reduced 13.56%
5,174 $54,000
Q1 2024

Apr 18, 2024

SELL
$11.27 - $13.53 $15,383 - $18,468
-1,365 Reduced 18.57%
5,986 $71,000
Q4 2023

Feb 05, 2024

SELL
$8.77 - $10.85 $30,247 - $37,421
-3,449 Reduced 31.94%
7,351 $79,000
Q3 2023

Oct 23, 2023

BUY
$9.59 - $11.35 $13,378 - $15,833
1,395 Added 14.83%
10,800 $106,000
Q2 2023

Jul 24, 2023

BUY
$9.02 - $10.29 $11,897 - $13,572
1,319 Added 16.31%
9,405 $93,000
Q1 2023

Apr 24, 2023

BUY
$9.2 - $12.26 $29,587 - $39,428
3,216 Added 66.04%
8,086 $77,000
Q4 2022

Jan 13, 2023

BUY
$8.72 - $11.56 $6,923 - $9,178
794 Added 19.48%
4,870 $0
Q3 2022

Oct 17, 2022

BUY
$8.48 - $11.13 $20,411 - $26,789
2,407 Added 144.22%
4,076 $35,000
Q2 2022

Jul 21, 2022

SELL
$9.95 - $12.27 $89 - $110
-9 Reduced 0.54%
1,669 $17,000
Q1 2022

Apr 13, 2022

SELL
$9.81 - $15.4 $353 - $554
-36 Reduced 2.1%
1,678 $18,000
Q4 2021

Jan 27, 2022

SELL
$12.09 - $14.68 $1,051 - $1,277
-87 Reduced 4.83%
1,714 $23,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $4,134 - $4,720
-312 Reduced 14.77%
1,801 $24,000
Q2 2021

Aug 11, 2021

BUY
$12.97 - $16.15 $583 - $726
45 Added 2.18%
2,113 $30,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $774 - $1,056
-57 Reduced 2.68%
2,068 $28,000
Q4 2020

Feb 05, 2021

BUY
$14.3 - $18.74 $30,387 - $39,822
2,125 New
2,125 $39,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.